As Louisiana prepares to enforce a controversial new law on October 1, 2024, the Louisiana Abortion Fund has issued a sharp critique of the state’s decision to categorize the widely used abortion medications mifepristone and misoprostol as “controlled dangerous substances.” Executive Director Chasity Wilson spoke out against the move, warning of the potentially devastating impact […]
New Orleans, LA, June 27, 2024— The Louisiana Abortion Fund released the following statement in response to the Supreme Court’s limited ruling: “The Supreme Court’s limited ruling allowing for abortions to take place in Idaho for the time being under the Emergency Medical Treatment and Labor Act is cold comfort to the millions of birthing people […]
New Orleans, LA, June 13, 2024— The Louisiana Abortion Fund released the following statement in response to the Supreme Court’s ruling unanimously rejecting restrictions on the widely used medication mifepristone: “The Supreme Court’s ruling maintains mifepristone’s broad accessibility, in line with what medical experts, the FDA, and those who have been working to improve reproductive healthcare […]
Reproductive rights advocates and community members will gather Saturday, May 27 to celebrate the Louisiana Abortion Funds (LAAFs) new chapter. Formerly known as the New Orleans Abortion Fund, the re-energized fund is committed to reproductive justice the rights of all to determine if or when they will have children and the right to live […]
Go to Page